Novo Nordisk’s Wegovy made a significant impact on the obesity market when it launched in 2021.
Tirzepatide outpacing Wegovy in the obesity space
January 2, 2025
Novo Nordisk’s Wegovy made a significant impact on the obesity market when it launched in 2021.